Which type of insulin can never be mixed with another?

Appeared in: BHU NO-2019

Explanation

Long-acting insulins, such as glargine and detemir, are specifically formulated to provide a slow, peakless release over approximately 24 hours.
Insulin glargine has an acidic pH (4.0) which causes it to precipitate when mixed with neutral pH insulins, altering its absorption profile.
Mixing long-acting insulin with any other insulin in the same syringe disrupts its mechanism of action, leading to unpredictable blood glucose control and loss of its long-duration effect.
Due to this chemical incompatibility, long-acting insulins must always be administered in a separate syringe.

Option A: Intermediate-acting insulin (NPH) is specifically designed to be mixed with other insulins.
Option B: Regular (short-acting) insulin is commonly mixed with NPH (intermediate-acting) insulin.
Option C: Rapid-acting insulins (e.g., lispro, aspart) can be mixed with NPH insulin.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Insulin mixing compatibility and administration rules as background academic context rather than a clinical decision trigger.
Incorrectly mixing insulins is a critical medication error that can lead to severe hypoglycemia or uncontrolled hyperglycemia, both of which are life-threatening.
Nurses must adhere strictly to insulin compatibility rules as a core patient safety competency. This includes the 'clear before cloudy' principle when mixing regular and NPH insulin.
What if a patient is prescribed both long-acting insulin (e.g., Lantus) and rapid-acting insulin (e.g., NovoLog) before a meal? The nurse must prepare two separate injections and administer them at two different sites to ensure the proper action of each insulin.

How to Approach the Question

First, identify the keyword in the question: 'never be mixed'. This indicates you are looking for an absolute rule.
Recall the main categories of insulin: rapid-acting, short-acting (Regular), intermediate-acting (NPH), and long-acting (glargine, detemir).
Think about the purpose of each type. Rapid and short-acting cover meals. Intermediate and long-acting provide basal (background) coverage.
Remember the common practice of mixing 'clear' (Regular/Rapid) with 'cloudy' (NPH) insulin. This immediately eliminates three of the options as insulins that can be mixed.
Focus on the unique properties of long-acting insulins. Their formulation is designed for a very slow, steady release. Recall that this property is due to a specific chemical structure (e.g., acidic pH for glargine) that is disrupted upon mixing.
Conclude that long-acting insulin is the only type that has an absolute contraindication for mixing.

Concept Tested & Keywords

QSe17EGmd7BxiXBpTAf5oc

E6 Pharmacology Katzung 16e p. 1177-1179

E6 Ghai Essential Pediatrics(pp 26-904 of 913) p. 564-566

Practise the full BHU NO-2019

Attempt every question from this paper in a timed mock, then review the full solution for each one.